On World Hepatitis Day, medical experts from Beijing and Chicago highlighted groundbreaking progress in combating liver cancer through cross-border collaboration. China's hepatitis B vaccination rate for newborns now exceeds 95%, achieving a key World Health Organization target seven years ahead of schedule, according to Peking Union Medical College Hospital's Professor Mao Yilei.
"The incidence of HBV in children under five has plummeted to 0.3% – a testament to China's robust public health infrastructure," Mao told CGTN's Health Talk. This achievement gains significance as chronic HBV infection remains a leading cause of liver cancer worldwide.
University of Chicago Medicine's Professor Michael Millis emphasized the critical need for early detection: "Regular screenings every six months for high-risk groups can mean the difference between treatable lesions and advanced cancer." Both experts advocate combining ultrasound and CT scans for optimal monitoring.
The medical pioneers detailed their trans-Pacific partnership through student exchanges and joint conferences, creating a model for global health cooperation. "By sharing imaging analysis techniques and surgical innovations, we're developing protocols that benefit patients worldwide," Millis noted.
